• For Researchers

Celebrating excellence in our research community

We’re delighted to congratulate members of our research community recently elected to several prestigious organisations. We’re delighted to congratulate members of our research community recently elected to several prestigious organisations.

8 June 2018

• Charity News

Cancer Research UK announces new chief business officer

Cancer Research UK has appointed Tony Hickson as the charity’s new chief business officer. Cancer Research UK has appointed Tony Hickson as the charity’s new chief business officer.

8 June 2018

• Health & Medicine

Ex-smokers might be better off with high rather than low nicotine e-cigs

Vapers using low rather than high nicotine e-cigarettes may be using their devices more intensely, potentially increasing the risk of exposure to toxins. Vapers using low rather than high nicotine e-cigarettes may be using their devices more intensely, potentially increasing the risk of exposure to toxins.

8 June 2018

• Health & Medicine

Prostate cancer drug given initial ‘no’ for NHS in England

The prostate cancer drug abiraterone has been provisionally rejected as a first-line treatment on the NHS in England. The prostate cancer drug abiraterone has been provisionally rejected as a first-line treatment on the NHS in England.

7 June 2018

• Health & Medicine

Older breast cancer patients in England less likely to survive than in four other European countries

Older women diagnosed with breast cancer in England are less likely to survive their disease than those in Belgium, Poland, Ireland and the Netherlands. Older women diagnosed with breast cancer in England are less likely to survive their disease than those in Belgium, Poland, Ireland and the Netherlands.

7 June 2018

• Health & Medicine

Lung cancer immunotherapy drug approved for England

The lung cancer immunotherapy drug pembrolizumab has been made widely available on the NHS in England after a price deal was reached. The lung cancer immunotherapy drug pembrolizumab has been made widely available on the NHS in England after a price deal was reached.

6 June 2018

• Health & Medicine

Combining heartburn drugs and aspirin could help prevent oesophageal cancer in people at high risk

Two over-the-counter, widely available drugs could help cut cases of oesophageal cancer in people at higher risk of the disease. Two over-the-counter, widely available drugs could help cut cases of oesophageal cancer in people at higher risk of the disease.

4 June 2018

• Health & Medicine

Chemo combo could help pancreatic cancer patients live longer after surgery

A combination of chemotherapy drugs was better than a single drug at extending the lives of pancreatic cancer patients after surgery. A combination of chemotherapy drugs was better than a single drug at extending the lives of pancreatic cancer patients after surgery.

4 June 2018

• Health & Medicine

Chemoradiotherapy before surgery may extend lives of pancreatic cancer patients

Pancreatic cancer patients treated with chemotherapy and radiotherapy before surgery may live longer than those who have immediate surgery. Pancreatic cancer patients treated with chemotherapy and radiotherapy before surgery may live longer than those who have immediate surgery.

4 June 2018

• Health & Medicine

Taking aspirin and anti-acid reflux medication prevents oesophageal cancer in high risk patients

Taking an anti-acid reflux medication together with a low dose of aspirin can prevent oesophageal cancer in people with a high risk of the disease. Taking an anti-acid reflux medication together with a low dose of aspirin can prevent oesophageal cancer in people with a high risk of the disease.

4 June 2018

• Health & Medicine

Some people with advanced kidney cancer could avoid surgery

The targeted drug sunitinib is as effective alone as when it’s combined with surgery for some people with advanced kidney cancer. The targeted drug sunitinib is as effective alone as when it’s combined with surgery for some people with advanced kidney cancer.

3 June 2018

• Health & Medicine

Breast cancer gene test could spare some women chemo

A test that measures gene activity can help tailor treatment for some women with early stage breast cancer, sparing them chemotherapy. A test that measures gene activity can help tailor treatment for some women with early stage breast cancer, sparing them chemotherapy.

3 June 2018